ANVS
Annovis Bio Inc
1.20$
+0.9%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -0.1% | -23.5% | -35.4% | +184.6% | -3.0% | +92.0% | -19.8% | -19.9% | +22.6% | -22.9% | +35.7% | |
| – | -0.1% | -23.5% | -35.4% | +184.6% | -3.0% | +92.0% | -19.8% | -19.9% | +22.6% | -22.9% | +15.3% | |
| – | -9.4% | -45.5% | +27.4% | +216.1% | -16.5% | +110.7% | -23.0% | -10.8% | +27.8% | -27.2% | +31.7% | |
| – | -9.4% | -45.5% | +27.4% | +216.1% | -16.5% | +110.7% | -23.0% | -10.8% | +27.8% | -27.2% | +31.7% | |
| – | +403.8% | -37.8% | -39.1% | +7.4% | -36.7% | -41.9% | +16.4% | +29.1% | +4.9% | +210.1% | +100.4% | |
| – | +20.0% | +13.8% | -16.7% | +32.9% | -28.0% | -35.5% | +12.0% | +33.1% | -2.6% | +251.8% | -50.3% | |
| – | -32.9% | +217.7% | -17.3% | +20.8% | -43.7% | -40.6% | -28.9% | +116.8% | +22.7% | +103.6% | -36.9% | |
| – | -216.4% | – | – | – | +31.8% | +158.4% | -23.8% | -28.2% | +28.1% | -81.4% | -236.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +5.7% | +11.5% | +6.4% | +14.8% | +6.3% | +26.4% | +11.8% | +1.0% | +26.0% | +12.2% | +34.7% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.